Back

A manual synchronous low energy shock impedance as a predictor of successful defibrillation testing during subcutaneous icd implantation.

17 April 2023 (15:40 - 16:40)
Organised by:
Congress Presentation Part of: Device Therapy - ICD Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Carlos Ruben Lopez Perales

UNIVERSITY HOSPITAL MIGUEL SERVET, Zaragoza (Spain)

8 More presentations in this session

Presentation thumbnail
ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
Doctor T. Kleemann (Ludwigshafen, DE)
Abstract Slides
Presentation thumbnail
Automatic subcutaneous defibrillator screening in patients with intracardiac devices: comparative study depending on the point of pacing
Doctor E. Cabrera Borrego (Granada, ES)
Abstract Slides
Presentation thumbnail
Clinical predictors of very low defibrillation threshold in the extravascular ICD
Doctor F. Murgatroyd (London, GB)
Abstract Slides
Presentation thumbnail
Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up
Ms J. De Veld (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
The last shall be the first: the role of combined QLV- and CMR-determined electromechanical concordance in predicting optimal left ventricular stimulation site in cardiac resynchronisation therapy.
Doctor M. Bertelli (Bologna, IT)
Abstract Slides

Access the full session

Session thumbnail
Device Therapy - ICD

The Event

Event poster

EHRA 2023

17 April 2023 15:40 CET
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources